Opening marks company’s fourth center offering monitored ketamine care in the Washington, D.C., Maryland and Virginia (DMV) area
COLUMBIA, Md., February 28, 2025 – Avesta Ketamine and Wellness (Avesta), the leading provider of monitored ketamine care in the Washington, D.C., Maryland and Virginia (DMV) area, announced today the opening of its fourth ketamine clinic in the region. Located at 5840 Banneker Road, Suite 270 in Columbia, Maryland, the new center strengthens Avesta’s commitment to providing transformative, evidence based mental health and pain management care in safe, monitored environments. It joins Avesta’s existing clinics in NW Washington, D.C., Bethesda, Maryland, and McLean, Virginia.
“Ketamine offers profound relief for people struggling with treatment-resistant depression, PTSD, anxiety, substance use disorder (SUD), and chronic pain,” said Dr. Ladan Eshkevari, CRNA, PhD, FAAN, founder and co-CEO of Avesta. “Too many people spend years cycling through medications and traditional therapies without improvement. With our new clinic in Columbia, we can provide more people with rapid relief in a calm, convenient, and clinically supervised setting.”
The new clinic will offer a range of ketamine therapy protocols, including IV ketamine therapy, FDA-approved Spravato™ therapy, ketamine-assisted psychotherapy (KAP), and IV vitamins. Avesta works closely with patients’ mental health providers to customize treatments for each person’s needs, medical history, and personal goals.
Avesta’s Columbia ketamine clinic increases access to life-changing treatment in Howard County, where suicide is the second leading cause of death for youth ages 15-19, and two in five adults regularly struggle with poor mental health, according to the Howard County Health Department’s December 2023 “Report Card of Community Health Indicators”.
“As part of Avesta’s patient-first approach, we are committed to making ketamine therapy more accessible to Columbia area residents while simplifying the insurance process,” said Deborah Tan, Avesta’s co-CEO. “We know that seeking ketamine therapy is a big decision, so our team works diligently to ease financial barriers to treatment, particularly for those who feel like they have run out of options. Our compassionate, collaborative and patient-first approach continues to raise DMV’s standard for safe and effective healing.”
Avesta’s clinical team is led by Dr. Eshkevari, who has over 30 years of anesthesia, pain management, and alternative medicine experience. A professor emeritus at Georgetown University, she has trained many of the region’s top providers and helped set ketamine protocol standards in the DMV area. Dr. Eshkevari’s deep expertise ensures that Avesta’s clinicians closely monitor infusions, adjust treatments as needed, and coordinate with patients’ providers to optimize results. The team includes a board-certified anesthesiologist, nurse anesthetists, nurse practitioners, integration specialists, medical assistants, a team dedicated to helping patients with insurance, and patient care coordinators.
For more information, visit www.avestaketaminewellness.com
About Avesta Ketamine and Wellness
Avesta Ketamine and Wellness is the longest-standing IV ketamine and Spravato™ provider in the DMV area. It has administered over 10,000 ketamine infusions for depression, anxiety, PTSD, migraines, fibromyalgia, and chronic pain in the last eight years. Founded by Dr. Ladan Eshkevari, CRNA, PhD, FAAN, Avesta draws from varied expertise in anesthesia, pain management, mental health, and advanced practice nursing creating custom protocols with the highest safety standards.
###
Media Contact:
McKenzie Hyde
